Bolt Biotherapeutics, Inc. (BOLT)
4.56
-0.05
(-1.08%)
USD |
NASDAQ |
May 21, 16:00
4.56
0.00 (0.00%)
After-Hours: 19:59
Bolt Biotherapeutics Total Assets (Quarterly) : 48.03M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Humacyte, Inc. | 110.56M |
| ACADIA Pharmaceuticals, Inc. | 1.605B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Amgen, Inc. | 92.50B |
| Savara, Inc. | 221.64M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.20M |
| Shareholders Equity (Quarterly) | 19.82M |
| Debt to Equity Ratio | 1.125 |
| Current Ratio | 3.507 |
| Net Debt Paydown Yield | 7.48% |